دورية أكاديمية
أعرض في EDS

Sarcoidosis: a general overview.

التفاصيل البيبلوغرافية
العنوان: Sarcoidosis: a general overview.
المؤلفون: Neves FS; Internal Medicine Department, Rheumatology Division, Health Sciences Center, Universidade Federal de Santa Catarina (UFSC), Florianópolis, Brazil. fabricio.souza.neves@ufsc.br., Pereira IA; Medicine School, Rheumatology Division, Universidade do Sul de Santa Catarina (UNISUL), Palhoça, Brazil., Sztajnbok F; Department of Pediatrics, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Neto NSR; Centro de Doenças Raras e da Imunidade, Hospital Nove de Julho, São Paulo, Brazil.; Universidade Santo Amaro, São Paulo, Brazil.
المصدر: Advances in rheumatology (London, England) [Adv Rheumatol] 2024 Aug 12; Vol. 64 (1), pp. 57. Date of Electronic Publication: 2024 Aug 12.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101734172 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3106 (Electronic) Linking ISSN: 25233106 NLM ISO Abbreviation: Adv Rheumatol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, [2018]-
مواضيع طبية MeSH: Sarcoidosis*/diagnosis, Humans ; Sarcoidosis, Pulmonary
مستخلص: Sarcoidosis is a systemic inflammatory disease of unknown origin, which consists of the formation of multiple sterile noncaseating granulomas. Inhaled antigens are believed to initiate disease in prone individuals, considering that almost all patients present pulmonary or mediastinal lymph node disease. Extrapulmonary manifestations are common and diverse: practically any organ system can be affected, and treatment can range from simple watchful waiting to intense immunosuppression. In this article, we review current concepts about sarcoidosis in an overview, focusing on recognition and treatment of its major clinical phenotypes.
(© 2024. The Author(s).)
References: Rossides M, Darlington P, Kullberg S, Arkema EV. Sarcoidosis: Epidemiology and clinical insights. J Intern Med. 2023;293:668–80. https://doi.org/10.1111/joim.13629 . (PMID: 10.1111/joim.1362936872840)
Levin MA, Adrianto I, Datta I, et al. Association of HLA-DRB1 with Sarcoidosis susceptibility and progression in African americans. Am J Respir Cell Mol Biol. 2015;53:206–16. https://doi.org/10.1165/rcmb.2014-0227OC . (PMID: 10.1165/rcmb.2014-0227OC255067224566045)
Sikorova K, Osoegawa K, Kocourkova L, et al. Association between sarcoidosis and HLA polymorphisms in a Czech population from Central Europe: focus on a relationship with clinical outcome and treatment. Front Med. 2023. https://doi.org/10.3389/fmed.2023.1094843 . (PMID: 10.3389/fmed.2023.1094843)
Inaoka PT, Shono N, Kamada M, Espinoza JL. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis. J Biomed Sci. 2019;26:45. https://doi.org/10.1186/s12929-019-0537-6 . (PMID: 10.1186/s12929-019-0537-6311820926558716)
Graff P, Larsson J, Bryngelsson IL, Wiebert P, Wihlborg P. Sarcoidosis and silica dust exposure among men in Sweden: a case-control study. BMJ Open. 2020;10(9):e038926. https://doi.org/10.1136/bmjopen-2020-038926 . (PMID: 10.1136/bmjopen-2020-038926328837397473614)
Beijer E, Meek B, Bossuyt X, et al. Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients. Respir Res. 2020;21:141. https://doi.org/10.1186/s12931-020-01409-w . (PMID: 10.1186/s12931-020-01409-w325131597282065)
Greaves AS, Atif SM, Fontenot AP. eCollection. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease. Front Immunol 2020:11:474. https://doi.org/10.3389/fimmu.2020.00474 . 2020.
Cooper D, Suau S, Sarcoidosis. Immunol Allergy Clin N Am. 2023;583–91. https://doi.org/10.1016/j.iac.2022.10.011 .
Binesh F, Halvani H, Navabii H. BMJ Case Rep. 2012. https://doi.org/10.1136/bcr.05.2011.4278 . bcr0520114278. (PMID: 10.1136/bcr.05.2011.4278232572694544891)
Te HS, Perlman DM, Shenoy C, et al. Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts. BMC Pulm Med. 2020;20:155. https://doi.org/10.1186/s12890-020-01191-x . (PMID: 10.1186/s12890-020-01191-x324871347268634)
Shupp JC, Freitag-Wolf S, Bargagli E et al. Phenotypes of organ involvement in sarcoidosis. Eur Resp J 2018 51: 1700991. https://doi.org/10.1183/13993003.00991-2017 .
Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2:1165–72. https://doi.org/10.1136/bmj.2.5261.1165 . (PMID: 10.1136/bmj.2.5261.1165144977501970202)
Levy A, Hamzeh N, Maier LA, F1000Res. Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis?. 2018; 7: F1000 Faculty Rev-600. https://doi.org/10.12688/f1000research.11068.1 .
Maña J, Gómez-Vaquero C, Montero A, et al. Löfgren’s syndrome revisited: a study of 186 patients. Am J Med. 1999;107:240–2455. https://doi.org/10.1016/s0002-9343(99)00223-5 . (PMID: 10.1016/s0002-9343(99)00223-510492317)
Denny MC, Fotino AD. The Heerfordt-Waldenström syndrome as an initial presentation of sarcoidosis. Proc (Bayl Univ Med Cent). 2013;26:390. https://doi.org/10.1080/08998280.2013.11929014 . (PMID: 10.1080/08998280.2013.1192901424082416)
Crombag LMM, Moij-Kalverda K, Szlubowski A, et al. EBUS versus EUS-B for diagnosing sarcoidosis: the International Sarcoidosis Assessment (ISA) randomized clinical trial. Respirology. 2022;27:152–60. https://doi.org/10.1111/resp.14182 . (PMID: 10.1111/resp.1418234792268)
Darlinton P, Kullberg S, Eklund A, et al. Lung CD4 + Vα2.3 + T-cells in sarcoidosis cohorts with Löfgren’s syndrome. Respir Res. 2020;21:61. https://doi.org/10.1186/s12931-020-1327-0 . (PMID: 10.1186/s12931-020-1327-0)
Shen Y, Pang C, Wu Y et al. Diagnostic performance of Bronchoalveolar Lavage Fluid CD4/CD8 ratio for sarcoidosis: a Meta-analysis. EBioMedicine 2016:8:302–8. https://doi.org/10.1016/j.ebiom.2016.04.024 .
Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31:404. https://doi.org/10.1055/s-0030-1262207 . (PMID: 10.1055/s-0030-126220720665390)
Ramos-Casals M, Retamozo S, Sisó-Almiral A, et al. Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert Rev Clin Immunol. 2019;15:391–405. https://doi.org/10.1080/1744666X.2019.1568240 . (PMID: 10.1080/1744666X.2019.156824030632406)
Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020;29:190146. https://doi.org/10.1183/16000617.0146-2019 . (PMID: 10.1183/16000617.0146-2019321982189488897)
Baughman RP, Niranjan V, Walker G, et al. Efzofitimod: a novel anti-inflammatory agent for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2023;40:e2023011. https://doi.org/10.36141/svdld.v40i1.14396 . (PMID: 10.36141/svdld.v40i1.143963697505110099656)
Grunewald J, Grutters JC, Arkema EV, et al. Sarcoidosis Nat Rev Dis Primers. 2019;5:45. https://doi.org/10.1038/s41572-019-0096-x . (PMID: 10.1038/s41572-019-0096-x31273209)
Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and its management. N Engl J Med. 2021;385:1018–32. https://doi.org/10.1056/NEJMra2101555 . (PMID: 10.1056/NEJMra210155534496176)
Janssen MTHF, Landewé RBM, Post MC, et al. Organ involvement and assessment in sarcoidosis. Curr Opin Pulm Med. 2023;29:485–92. https://doi.org/10.1097/MCP.0000000000000997 . (PMID: 10.1097/MCP.000000000000099737461850)
Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31:1189. https://doi.org/10.1183/09031936.00051907 . (PMID: 10.1183/09031936.0005190718256069)
Evans M, Sharma O, LaBree L, Smith RE, Rao NA. Differences in clinical findings between caucasians and African americans with biopsy-proven sarcoidosis. Ophthalmology. 2007;114:325–33. https://doi.org/10.1016/j.ophtha.2006.05.074 . (PMID: 10.1016/j.ophtha.2006.05.07417123620)
Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of Sarcoidosis. An official American thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201:e26. https://doi.org/10.1164/rccm.202002-0251ST . (PMID: 10.1164/rccm.202002-0251ST322932057159433)
Sève P, Jamilloux Y, Tilikete C, et al. Ocular Sarcoidosis. Semin Respir Crit Care Med. 2020;41:673–88. https://doi.org/10.1055/s-0040-1710536 . (PMID: 10.1055/s-0040-171053632777852)
Mochizuki M, Smith JR, Takase H, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103:1418. https://doi.org/10.1136/bjophthalmol-2018-313356 .
Matsou A, Tsaousis TT. Management of chronic ocular sarcoidosis: challenges and solutions. Clin Ophthalmol. 2018;12:519–32. https://doi.org/10.2147/OPTH.S128949 . (PMID: 10.2147/OPTH.S128949295933775863717)
Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. cutaneous disease. J Am Acad Dermatol. 2012;66:699e1. https://doi.org/10.1016/j.jaad.2011.11.965 . (PMID: 10.1016/j.jaad.2011.11.965)
Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2010;31:442–51. https://doi.org/10.1055/s-0030-1262212 .
Yatsynovich Y, Dittoe N, Petrov M, et al. Cardiac sarcoidosis: a review of Contemporary challenges in diagnosis and treatment. Am J Med Sci. 2018;355:113–25. https://doi.org/10.1016/j.amjms.2017.08.009 . (PMID: 10.1016/j.amjms.2017.08.00929406038)
Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33:1344–52. https://doi.org/10.1111/echo.13281 . (PMID: 10.1111/echo.13281276776425523448)
Kouranos V, Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart. 2021;107:1591–9. https://doi.org/10.1136/heartjnl-2019-316442 . (PMID: 10.1136/heartjnl-2019-31644233674355)
Masri SC, Bellumkonda L. Sarcoid Heart Disease: an update on diagnosis and management. Curr Cardiol Rep. 2020;22:177. https://doi.org/10.1007/s11886-020-01429-4 . (PMID: 10.1007/s11886-020-01429-433119794)
Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16:2. https://doi.org/10.1097/NRL.0b013e3181c92a72 . (PMID: 10.1097/NRL.0b013e3181c92a7220065791)
Menninger MD, Amdur RJ, Marcus RB Jr. Role of radiotherapy in the treatment of neurosarcoidosis. Am J Clin Onco. 2003;26:e115. https://doi.org/10.1097/01.COC.0000077933.69101.5D . (PMID: 10.1097/01.COC.0000077933.69101.5D)
Werner J, Rivera N, Grunewald J, et al. HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis. Respir Med. 2021;187:106537. https://doi.org/10.1016/j.rmed.2021.106537 . (PMID: 10.1016/j.rmed.2021.10653734325227)
Rastelli F, Baragetti I, Buzzi L, et al. Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38:e2021017. https://doi.org/10.36141/svdld.v38i3.11488 . (PMID: 10.36141/svdld.v38i3.11488347444178552569)
Sharma A, Kadakia J, Sharma O. Gastrointestinal Sarcoidosis. Sem Respir Med. 1992;6:442. https://doi.org/10.1055/s-2007-1006293 . (PMID: 10.1055/s-2007-1006293)
Cremers JP, Drent M, Baughman RP et al. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med;18:472–82. https://doi.org/10.1097/MCP.0b013e3283541626 .
Hangül M, Köse M, Pekcan S, Ersoy A, Unal G, Caglar HT. Childhood sarcoidosis in the middle Anatolia of Turkey. Pediatr Pulmonol. 2023. https://doi.org/10.1002/ppul.26564 . (PMID: 10.1002/ppul.2656437341617)
Kaufman K, Becker ML. Distinguishing Blau Syndrome from systemic sarcoidosis. Curr Allergy Asthma Rep. 2021;21:10. https://doi.org/10.1007/s11882-021-00991-3 . (PMID: 10.1007/s11882-021-00991-3335604459762981)
فهرسة مساهمة: Keywords: Noncaseating granuloma; Rare diseases; Review; Sarcoidosis
تواريخ الأحداث: Date Created: 20240812 Date Completed: 20240813 Latest Revision: 20240812
رمز التحديث: 20240813
DOI: 10.1186/s42358-024-00381-z
PMID: 39135190
قاعدة البيانات: MEDLINE
الوصف
تدمد:2523-3106
DOI:10.1186/s42358-024-00381-z